New data for Pfizer arthritis pill
September 18, 2012Research and Development, Sales and Marketing JAK, Pfizer, RA, tofacitinib
Pfizer is to release more data for its investigational rheumatoid arthritis (RA) pill tofacitinib which it hopes will demonstrate its …
Helix Health appoints John Evans as UK commercial manager
September 18, 2012Medical Communications, Research and Development, Sales and Marketing Helix Health, John Evans
Healthcare IT provider Helix Health has recruited John Evans to the role of UK commercial manager to expand its UK …
SHL to Exhibit at 2012 PDA Event in Las Vegas – Inspiring Integration
September 18, 2012Manufacturing and Production auto injector, autoinjector, inspiring integration, pen injector, shl group
With the biopharmaceutical industry’s drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a …
AstraZeneca signs MIT/Harvard research deal
September 17, 2012Business Services, Research and Development, Sales and Marketing AstraZeneca, Deals, Havard, MIT
AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
Pharma manufacturing news in brief
September 17, 2012Manufacturing and Production Ampio, DPT Labs, Ethypharm, ICH, PC Pharma, Ranbaxy
Ranbaxy and PC Pharma unveil new facility investments, Ethypharm will manufacture Ampio drug, DPT Labs is warned by the FDA …
Doctors.net.uk appoints new business development manager
September 17, 2012Business Services, Medical Communications, Sales and Marketing Marc Singh-Jones, doctors.net
The UK’s largest and most active network of medical professionals Doctors.net.uk has appointed Marc Singh-Jones as Business Development manager. In …
Boehringer beta launches Syrum on Facebook
September 17, 2012Medical Communications, Sales and Marketing Boehringer, Facebook, Syrum
Boehringer Ingelheim has announced the beta launch of its first social game on Facebook, the eagerly-awaited Syrum. Other sectors have …
Astellas appoints Jo Underhill as Sales and Marketing director
September 14, 2012Business Services, Research and Development, Sales and Marketing Astellas, Jo Underhill
Astellas Pharma has appointed Jo Underhill as Sales and Marketing director, Urology/Dermatology, completing its UK management team. Reporting directly to …
Eisai launches epilepsy drug in UK
September 14, 2012Sales and Marketing Eisai, UK, epilepsy
Eisai has launched its first-in-class epilepsy drug Fycompa in the UK, prior to a roll-out in EU member states including …
New chief executive for Havas Worldwide Health
September 14, 2012Business Services, Medical Communications, Sales and Marketing Ben Davies, Havas Worldwide Health
Comms agency Havas Worldwide Health has announced the selection of Ben Davies as chief executive of its European division. Davies …
Online programme to help diabetes patients
September 14, 2012Medical Communications, Sales and Marketing Boehringer, diabetes, lilly
Boehringer Ingelheim and Eli Lilly have launched an online initiative which they say will help diabetes sufferers make simple lifestyle …
Pfizer and Hisun sign China generics deal
September 13, 2012Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics
Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …
The ex-CEO’s Job Blog – part 2
September 13, 2012Sales and Marketing Jobs, careers, interviews, the ex-CEO's job blog
Would you believe everything a used car salesman tells you? Of course not. So why do so many people accept …
Setback for Sanofi dengue vaccine
September 13, 2012Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine
Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …
Hospitals on ‘brink of collapse’, warn doctors
September 13, 2012NHS, NHS reform, NHS reforms, QIPP, Sir John Oldham
Hospitals across the UK are struggling to cope with emergency admissions, and a doctors’ group has warned that patient safety …
Genzyme MS drug approved in US
September 13, 2012Medical Communications Aubagio, Genzyme, Rebif, Sanofi, Tysabri, gilenya, multiple sclerosis
US regulators have given the green light for Genzyme’s Aubagio to treat patients with relapsing forms of multiple sclerosis (MS). …
GPs can access patient records via tablet devices
September 12, 2012Medical Communications Digital Blog, GPs, NHS, ipad
The first ever service allowing GPs to access and update their patient records using an iPad or other tablet device …
Pharma thumbs-up for government innovation centre
September 12, 2012Research and Development, Sales and Marketing ABPI, synthetic biology
The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …
New frontiers in drug discovery
September 11, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic
Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
